Protecting Bioprocessing Operations And Supply Chains In A Turbulent Economy

Resilience is critical in biomanufacturing, especially in an increasingly connected global ecosystem where economic shifts in one region can threaten operations everywhere. Join Bioprocess Online’s chief editor, Tyler Menichiello, for an interactive panel discussion on how companies are navigating a tight funding environment, raw material shortages, and global market pressures. The panel will feature Adam Golin, a senior director of manufacturing at Sanofi; Jon Lindbloom, the director of technical operations at Vaxart; and veteran industry leader James Sapirstein.

Explore the ways inflation, energy costs, and supply chain disruptions are reshaping operations and learn what biotech companies can do to stay resilient during times of economic turbulence.